IMRIS CEO Jay D. Miller to Present at Canaccord Genuity 33rd Annual Global Growth Conference

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WINNIPEG and MINNEAPOLIS, Aug. 9, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the Canaccord Genuity 33rd Annual Global Growth Conference in Boston at 10 am Eastern Time on Thursday, August 15.

The slides of Mr. Miller's presentation will be available at www.irmis.com, and can be found under Investors, Events & Presentations.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular, spinal and cerebrovascular markets and have been selected by 54 leading medical institutions around the world. For more information, visit www.imris.com.

SOURCE IMRIS Inc.



Hey, check out all the engineering jobs. Post your resume today!

Back to news